BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27987201)

  • 1. Treatment of Acute Lymphoblastic Leukemia in Adults: Applying Lessons Learned in Children.
    Aldoss IT; Marcucci G; Pullarkat V
    Oncology (Williston Park); 2016 Dec; 30(12):1080-91. PubMed ID: 27987201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Young Adults with Acute Lymphoblastic Leukemia.
    Kansagra A; Litzow M
    Curr Hematol Malig Rep; 2017 Jun; 12(3):187-196. PubMed ID: 28353017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral and cellular immunotherapy in ALL in children, adolescents, and young adults.
    Hochberg J; El-Mallawany NK; Cairo MS
    Clin Lymphoma Myeloma Leuk; 2014 Sep; 14 Suppl():S6-13. PubMed ID: 25486958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal approach to the treatment of young adults with acute lymphoblastic leukemia in 2020.
    Rank CU; Schmiegelow K
    Semin Hematol; 2020 Jul; 57(3):102-114. PubMed ID: 33256899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.
    Topp MS; Gökbuget N; Stein AS; Zugmaier G; O'Brien S; Bargou RC; Dombret H; Fielding AK; Heffner L; Larson RA; Neumann S; Foà R; Litzow M; Ribera JM; Rambaldi A; Schiller G; Brüggemann M; Horst HA; Holland C; Jia C; Maniar T; Huber B; Nagorsen D; Forman SJ; Kantarjian HM
    Lancet Oncol; 2015 Jan; 16(1):57-66. PubMed ID: 25524800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approaches to the treatment of older adults with acute lymphoblastic leukemia.
    Schwartz M; Wieduwilt MJ
    Semin Hematol; 2020 Jul; 57(3):122-129. PubMed ID: 33256901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage therapy for children with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Kodama Y; Manabe A; Kawasaki H; Kato I; Kato K; Sato A; Matsumoto K; Kato M; Hiramatsu H; Sano H; Kaneko T; Oda M; Saito AM; Adachi S; Horibe K; Mizutani S; Ishii E; Shimada H
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28084041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
    Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
    Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors.
    Aldoss I; Bargou RC; Nagorsen D; Friberg GR; Baeuerle PA; Forman SJ
    Leukemia; 2017 Apr; 31(4):777-787. PubMed ID: 28028314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blinatumomab treatment of older adults with relapsed/refractory B-precursor acute lymphoblastic leukemia: Results from 2 phase 2 studies.
    Kantarjian HM; Stein AS; Bargou RC; Grande Garcia C; Larson RA; Stelljes M; Gökbuget N; Zugmaier G; Benjamin JE; Zhang A; Jia C; Topp MS
    Cancer; 2016 Jul; 122(14):2178-85. PubMed ID: 27143254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ALL in adult patients: Contribution and limits of pediatric management].
    Rabian F; Boissel N
    Bull Cancer; 2021 Feb; 108(2):187-197. PubMed ID: 32981690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute leukemia in adults].
    Eigendorff E; Hochhaus A
    Pathologe; 2015 Sep; 36(5):503-17; quiz 518-9. PubMed ID: 26314268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current treatment of adult acute lymphoblastic leukemia].
    Fujisawa S
    Rinsho Ketsueki; 2017; 58(10):1983-1994. PubMed ID: 28978840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults.
    Speziali C; Paulson K; Seftel M
    Curr Hematol Malig Rep; 2016 Jun; 11(3):175-84. PubMed ID: 26984203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Lymphoblastic Leukemia in the Older Adult.
    Aldoss I; Forman SJ; Pullarkat V
    J Oncol Pract; 2019 Feb; 15(2):67-75. PubMed ID: 30763199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuing challenges and current issues in acute lymphoblastic leukemia.
    Kansagra A; Dahiya S; Litzow M
    Leuk Lymphoma; 2018 Mar; 59(3):526-541. PubMed ID: 28604239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia.
    Assi R; Kantarjian H; Short NJ; Daver N; Takahashi K; Garcia-Manero G; DiNardo C; Burger J; Cortes J; Jain N; Wierda W; Chamoun S; Konopleva M; Jabbour E
    Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):897-901. PubMed ID: 28927784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of Adults with Acute Lymphoblastic Leukemia After Autologous Hematopoietic Stem Cell Transplantation and the Significance of Pretransplantation Minimal Residual Disease: Analysis from a Single Center of China.
    Ding Z; Han MZ; Chen SL; Ma QL; Wei JL; Pang AM; Zhang XY; Liang C; Yao JF; Cao YG; Feng SZ; Jiang EL
    Chin Med J (Engl); 2015 Aug; 128(15):2065-71. PubMed ID: 26228220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute lymphoblastic leukemia in adults.
    Narayanan S; Shami PJ
    Crit Rev Oncol Hematol; 2012 Jan; 81(1):94-102. PubMed ID: 21353591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.
    Ribera JM; Oriol A; Morgades M; Montesinos P; Sarrà J; González-Campos J; Brunet S; Tormo M; Fernández-Abellán P; Guàrdia R; Bernal MT; Esteve J; Barba P; Moreno MJ; Bermúdez A; Cladera A; Escoda L; García-Boyero R; Del Potro E; Bergua J; Amigo ML; Grande C; Rabuñal MJ; Hernández-Rivas JM; Feliu E
    J Clin Oncol; 2014 May; 32(15):1595-604. PubMed ID: 24752047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.